Sunny Pharmtech Inc. (TPEX:6676)

Taiwan · Delayed Price · Currency is TWD

12.20

-0.20 (-1.61%)

Aug 4, 2026, 1:59 PM CST

-16.44% (1Y)

Market Cap	1.83B -15.7%
Revenue (ttm)	253.01M -39.5%
Net Income	-302.05M
EPS	-2.03
Shares Out	148.84M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	204,360
Open	12.40
Previous Close	12.40
Day's Range	12.15 - 12.50
52-Week Range	11.95 - 19.85
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Sunny Pharmtech

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug formulations and raw materials in Taiwan, the United States, and internationally. It offers lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; and aminocaproic acid ta... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2014

Employees 158

Stock Exchange Taipei Exchange

Ticker Symbol 6676

Full Company Profile

Financial Performance

In 2025, Sunny Pharmtech's revenue was 253.01 million, a decrease of -39.47% compared to the previous year's 418.01 million. Losses were -302.05 million, 93.6% more than in 2024.

Financial Statements